Article
The metastatic capacity of high-grade serous ovarian cancer cells changes along disease…
medRxiv · 2022 · Ritch, S. J.; Noman, A. S.; Goyeneche, A. A.; Telleria, C. M.
Key facts
| Title | The metastatic capacity of high-grade serous ovarian cancer cells changes along disease progression: inhibition by mifepristone |
|---|---|
| First author | Ritch, S. J.; Noman, A. S.; Goyeneche, A. A.; Telleria, C. M. |
| Journal | medRxiv |
| Published | May 7, 2022 |
| DOI | 10.1101/2022.05.07.491021 |
| Devices mentioned | DEN000008, K022086, K103302, K802418, K831519, K843085, K845013, K850513, K851606, K870482, K870488, K870489 and 4 more |
| Product codes mentioned | JCI, KIT, NDS, NJT, OOI, KHS, KIP, KIS |
At a glance
- 10–99 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1